Roger Mills

Roger Mills

Director Técnico/Científico/I+D en ADDEX THERAPEUTICS LTD .

Fortuna: 39 362 $ al 30/06/2026

69 años
Health Technology
Consumer Services
Commercial Services

Perfil

Dr. Roger G.
Mills
, MD, is a Non-Executive Director & Chief Medical Officer at Addex Therapeutics Ltd. and a Director & Executive Vice President at San Diego Opera.
He is on the Board of Directors at Enterin, Inc., Addex Therapeutics Ltd. and San Diego Opera.
Dr. Mills was previously employed as a Chief Medical Officer & Executive VP-Development by ACADIA Pharmaceuticals, Inc., a Principal by Gilead Sciences, Inc., a Vice President-Development by Pfizer (St. Louis), and a Principal by Wellcome Foundation Ltd. He received his doctorate degree from Charing Cross Hospital Medical School.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
18/03/2026 785.976 ( 0,36 % ) 39 362 $ 30/06/2026

Cargos activos de Roger Mills

EmpresasCargoInicio
ADDEX THERAPEUTICS LTD Director Técnico/Científico/I+D 28/11/2016
Director/Miembro de la Junta -
Director/Miembro de la Junta 13/09/2021

Antiguos cargos conocidos de Roger Mills.

EmpresasCargoFin
ACADIA PHARMACEUTICALS INC. Director Técnico/Científico/I+D 04/11/2015
Corporate Officer/Principal -
Corporate Officer/Principal -
GILEAD SCIENCES, INC. Corporate Officer/Principal -
Ver el detalle de la experiencia de Roger Mills.

Formación de Roger Mills.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

57

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services